TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Research Contract Dollars Will Drop In 1980, But Will Increase Sharply for Some Programs July 7, 1978